A combination of pretherapy imaging and dosimetry can help ensure that patients with refractory differentiated thyroid cancer obtain the maximum benefit from radioactive iodine treatments following redifferentiation therapy. ...
Jun 22, 2023
0
4
Cancer is often thought of as a disease that affects older people, and with the median age of a cancer diagnosis at 66 years, it does. But cancer can be diagnosed at any age.
Sep 22, 2022
0
21
In a summary of a recent guideline from the National Institute for Health and Care Excellence (NICE), published online Jan. 29 in The BMJ, recommendations are presented for the assessment and management of thyroid disease.
Mar 4, 2020
0
0
Radioactive iodine is to be recommended as the frontline treatment for patients with thyroid gland overactivity caused by conditions such as Graves' disease, following an evidence review led by University of Birmingham researchers.
Jan 29, 2020
0
1
For many years, radioactive iodine which emits beta rays has been used for treatment of thyroid cancer. Generally, 5-year survival rates may exceed 90%. However, some thyroid tumors become resistant to iodine treatment ("iodine-refractory"), ...
Apr 2, 2019
0
1
Dear Mayo Clinic: I have had hyperthyroidism for just over one year, and medication does not seem to keep it in check. I do not want to have my thyroid removed. But I'm nervous about radioactive iodine treatment, which is ...
Dec 7, 2018
0
0
More imaging after thyroid cancer treatment identifies recurrence, but it does not always improve survival, a new study suggests.
Jul 20, 2016
0
0
Women of reproductive age who have thyroid cancer should be cautious about receiving radioactive iodine treatment, which affects their remaining egg supply - their ovarian reserve - and may affect their fertility, new research ...
Apr 3, 2016
0
1
In patients with advanced thyroid cancer, sunitinib, a drug approved for treatment of several other cancers, showed significant cancer-fighting activity t, a new phase 2 clinical trial has found. Results of the single-center ...
Mar 8, 2015
0
9
(Medical Xpress)—The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to a new study from researchers in the Abramson Cancer Center at the University ...
Apr 25, 2014
0
0
